偏头痛药物-话题@MedSci

#偏头痛药物#

6篇内容 | 664人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1989685, encodeId=7d72198968510, content=<a href='/topic/show?id=d66e2e61558' target=_blank style='color:#2F92EE;'>#偏头痛药物#</a>, objectTitle=J Headache Pain：2017-2020年偏头痛药物的使用和成本趋势, objectType=article, longId=737422, objectId=1cb3e37422b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cb3e37422b6, replyNumber=0, likeNumber=42, createdTime=2022-12-04, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cb3e37422b6, moduleTitle=J Headache Pain：2017-2020年偏头痛药物的使用和成本趋势, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cb3e37422b6)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1989684, encodeId=5397198968490, content=<a href='/topic/show?id=d66e2e61558' target=_blank style='color:#2F92EE;'>#偏头痛药物#</a>, objectTitle=辉瑞和 Biohaven 获得欧盟委员会对偏头痛药物 Vydura 的认可, objectType=article, longId=299740, objectId=7dce299e40a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7dce299e40a2, replyNumber=0, likeNumber=0, createdTime=2022-04-07, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7dce299e40a2, moduleTitle=辉瑞和 Biohaven 获得欧盟委员会对偏头痛药物 Vydura 的认可, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7dce299e40a2)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1989683, encodeId=0b7a19896835c, content=<a href='/topic/show?id=d66e2e61558' target=_blank style='color:#2F92EE;'>#偏头痛药物#</a>, objectTitle=每年5000英镑的治疗费用，诺华Erenumab偏头痛药物未达到NICE推荐标准, objectType=article, longId=180137, objectId=a97d18013e74, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a97d18013e74, replyNumber=0, likeNumber=36, createdTime=2020-05-11, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a97d18013e74, moduleTitle=每年5000英镑的治疗费用，诺华Erenumab偏头痛药物未达到NICE推荐标准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a97d18013e74)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1989682, encodeId=fcfd1989682b6, content=<a href='/topic/show?id=d66e2e61558' target=_blank style='color:#2F92EE;'>#偏头痛药物#</a>, objectTitle=由于细菌污染，辉瑞公司紧急召回偏头痛药物Relpax, objectType=article, longId=177797, objectId=88981e7797a2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=88981e7797a2, replyNumber=0, likeNumber=40, createdTime=2020-04-13, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=88981e7797a2, moduleTitle=由于细菌污染，辉瑞公司紧急召回偏头痛药物Relpax, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=88981e7797a2)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1989681, encodeId=d4cf19896818b, content=<a href='/topic/show?id=d66e2e61558' target=_blank style='color:#2F92EE;'>#偏头痛药物#</a>, objectTitle=Allergan的抗CGRP偏头痛药物试验成功, objectType=article, longId=129242, objectId=30c712924212, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=30c712924212, replyNumber=0, likeNumber=31, createdTime=2018-02-23, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=30c712924212, moduleTitle=Allergan的抗CGRP偏头痛药物试验成功, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=30c712924212)], followStatus=false, userIsMember=true, type=1, lengthMark=0), GetTopicListResponse(id=1989680, encodeId=f4db1989680e3, content=<a href='/topic/show?id=d66e2e61558' target=_blank style='color:#2F92EE;'>#偏头痛药物#</a>, objectTitle=Nature：抗体药物将重振偏头痛药物的开发, objectType=article, longId=17723, objectId=34091e7237a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34091e7237a, replyNumber=0, likeNumber=34, createdTime=2014-01-29, rootId=0, userName=wangtianj2007@, userId=7d74253, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34091e7237a, moduleTitle=Nature：抗体药物将重振偏头痛药物的开发, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34091e7237a)], followStatus=false, userIsMember=true, type=1, lengthMark=0)] 梅斯话题小助手

偏头痛药物

2020-05-29

(审核中...)

前往app查看评论内容

#偏头痛药物#

J Headache Pain：2017-2020年偏头痛药物的使用和成本趋势

2022-12-04

(审核中...)

前往app查看评论内容

#偏头痛药物#

辉瑞和 Biohaven 获得欧盟委员会对偏头痛药物 Vydura 的认可

2022-04-07

(审核中...)

前往app查看评论内容

#偏头痛药物#

每年5000英镑的治疗费用，诺华Erenumab偏头痛药物未达到NICE推荐标准

2020-05-11

(审核中...)

前往app查看评论内容

#偏头痛药物#

由于细菌污染，辉瑞公司紧急召回偏头痛药物Relpax

2020-04-13

(审核中...)

前往app查看评论内容

#偏头痛药物#

Allergan的抗CGRP偏头痛药物试验成功

2018-02-23

(审核中...)

前往app查看评论内容

#偏头痛药物#

Nature：抗体药物将重振偏头痛药物的开发

2014-01-29

科室
- - 订阅+
  - 更多科室
工具
服务